Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Genomic and Enzymology Research
4.2.2 Advancements in Tools for Synthetic Genome Design
4.2.3 Growing Demand for Personalized Medicine
4.3 Market Restraints
4.3.1 Lack of Skilled Professionals
4.3.2 High Cost and Complexity of Techniques
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Label Type
5.1.1 Biotin-based
5.1.2 Fluorescent
5.1.3 Radioactive
5.1.4 Other Label Types
5.2 By Application
5.2.1 Microarray
5.2.2 DNA Sequencing
5.2.3 In situ Hybridization
5.2.4 Polymerase Chain Reaction
5.2.5 Other Applications
5.3 By End User
5.3.1 Hospitals/Clinics
5.3.2 Diagnostic Centers
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Enzo Biochem Inc.
6.1.2 GE Healthcare
6.1.3 Marker Gene Technologies Inc.
6.1.4 Merck KGaA
6.1.5 New England Biolabs Inc.
6.1.6 PerkinElmer Inc.
6.1.7 Promega Corporation
6.1.8 Thermo Fisher Scientific
6.1.9 Vector Laboratories Inc.


7 MARKET OPPORTUNITIES AND FUTURE TRENDS